Oruka Therapeutics, Inc. ORKA Total Current Liabilities
Total Current Liabilities at other companies
Other financials
Where this comes from
Reported directly by Oruka Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:LiabilitiesCurrent.
The official record: Oruka Therapeutics, Inc.’s 10-Q, filed May 13, 2026, on SEC EDGAR. View the filing →
Ask your AI about Oruka Therapeutics, Inc.'s total current liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Oruka Therapeutics, Inc.'s total current liabilities?
- Oruka Therapeutics, Inc. (ORKA) reported total current liabilities of $16.63M in Q1 2026.
- How has Oruka Therapeutics, Inc.'s total current liabilities changed year-over-year?
- Oruka Therapeutics, Inc.'s total current liabilities increased by 41.9% year-over-year, from $11.72M to $16.63M.
- What is the long-term trend for Oruka Therapeutics, Inc.'s total current liabilities?
- Over 5 years (2020 to 2025), Oruka Therapeutics, Inc.'s total current liabilities has grown at a 34.5% compound annual growth rate (CAGR), from $3.5M to $15.37M.
- What does total current liabilities mean?
- The sum of all obligations due within one year — payables, accrued expenses, current debt, deferred revenue, and other short-term liabilities.